Toggle light / dark theme

Recent advances in AI are using deep learning to identify areas within human organs that surgeons can safely dissect before operating, machine learning to predict if patients with memory issues will develop Alzheimer’s within two years, and deep learning to analyze eye scans during routine examinations to identify patients at short-term high risk for a heart attack.


AI is being used for surgical guidance in the OR, for predicting early-onset Alzheimer’s, and through eye exams who may have a heart attack.

Research on proteins has been front and centre in our battle to defeat COVID-19. That’s why major efforts are being made to unlock the mystery of how combinations of amino acids when folded can be powerful tools in combatting diseases and more.


DeepMind in the UK and the University of Washington leading the way in proteins research to meet 21st-century problems and challenges.

As long as humans have built machines, we’ve feared the day they could destroy us. Stephen Hawking famously warned that AI could spell an end to civilization. But to many AI researchers, these conversations feel unmoored. It’s not that they don’t fear AI running amok—it’s that they see it already happening, just not in the ways most people would expect.

AI is now screening job candidates, diagnosing disease, and identifying criminal suspects. But instead of making these decisions more efficient or fair, it’s often perpetuating the biases of the humans on whose decisions it was trained.

BONN, Germany — When you’re sick, you can often see it in your face that you’re not feeling well. For rare diseases, it’s usually not that easy. However, researchers in Germany say artificial intelligence may change all that. A team from the University of Bonn say a new facial analysis program can actually detect the warning signs of rare diseases by examining the features of a person’s face.

“The goal is to detect such diseases at an early stage and initiate appropriate therapy as soon as possible,” says Prof. Dr. Peter Krawitz from the Institute for Genomic Statistics and Bioinformatics (IGSB) at the University Hospital Bonn in a university release.